GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Pretax Margin %

LAVA Therapeutics NV (LAVA Therapeutics NV) Pretax Margin % : -6.92% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. LAVA Therapeutics NV's Pre-Tax Income for the three months ended in Mar. 2024 was $-0.48 Mil. LAVA Therapeutics NV's Revenue for the three months ended in Mar. 2024 was $6.99 Mil. Therefore, LAVA Therapeutics NV's pretax margin for the quarter that ended in Mar. 2024 was -6.92%.

The historical rank and industry rank for LAVA Therapeutics NV's Pretax Margin % or its related term are showing as below:

LVTX' s Pretax Margin % Range Over the Past 10 Years
Min: -788.75   Med: -519.94   Max: -163.26
Current: -225.81


LVTX's Pretax Margin % is ranked worse than
54.78% of 1026 companies
in the Biotechnology industry
Industry Median: -154.275 vs LVTX: -225.81

LAVA Therapeutics NV Pretax Margin % Historical Data

The historical data trend for LAVA Therapeutics NV's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Pretax Margin % Chart

LAVA Therapeutics NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
- -423.91 -788.75 -163.26 -615.97

LAVA Therapeutics NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,133.09 -245.24 -16,577.36 -1,823.51 -6.92

Competitive Comparison of LAVA Therapeutics NV's Pretax Margin %

For the Biotechnology subindustry, LAVA Therapeutics NV's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LAVA Therapeutics NV's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LAVA Therapeutics NV's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where LAVA Therapeutics NV's Pretax Margin % falls into.



LAVA Therapeutics NV Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

LAVA Therapeutics NV's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-41.695/6.769
=-615.97 %

LAVA Therapeutics NV's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-0.484/6.992
=-6.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LAVA Therapeutics NV  (NAS:LVTX) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


LAVA Therapeutics NV Pretax Margin % Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

LAVA Therapeutics NV (LAVA Therapeutics NV) Headlines